annual CFO:
-$192.59M+$244.26M(+55.91%)Summary
- As of today (June 22, 2025), BPMC annual cash flow from operations is -$192.59 million, with the most recent change of +$244.26 million (+55.91%) on December 31, 2024.
- During the last 3 years, BPMC annual CFO has risen by +$106.07 million (+35.52%).
- BPMC annual CFO is now -149.76% below its all-time high of $387.04 million, reached on December 31, 2020.
Performance
BPMC Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$54.48M-$25.11M(-85.53%)Summary
- As of today (June 22, 2025), BPMC quarterly cash flow from operations is -$54.48 million, with the most recent change of -$25.11 million (-85.53%) on March 31, 2025.
- Over the past year, BPMC quarterly CFO has increased by +$47.03 million (+46.33%).
- BPMC quarterly CFO is now -108.75% below its all-time high of $622.33 million, reached on September 30, 2020.
Performance
BPMC quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$145.55M+$47.03M(+24.42%)Summary
- As of today (June 22, 2025), BPMC TTM cash flow from operations is -$145.55 million, with the most recent change of +$47.03 million (+24.42%) on March 31, 2025.
- Over the past year, BPMC TTM CFO has increased by +$269.85 million (+64.96%).
- BPMC TTM CFO is now -135.62% below its all-time high of $408.58 million, reached on June 30, 2021.
Performance
BPMC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BPMC Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.9% | +46.3% | +65.0% |
| 3 y3 years | +35.5% | +59.0% | +52.4% |
| 5 y5 years | +30.7% | +50.2% | +52.6% |
BPMC Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.7% | -299.5% | +59.0% | at high | +71.2% |
| 5 y | 5-year | -149.8% | +61.7% | -108.8% | +59.0% | -135.6% | +71.2% |
| alltime | all time | -149.8% | +61.7% | -108.8% | +59.0% | -135.6% | +71.2% |
BPMC Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$54.48M(+85.5%) | -$145.55M(-24.4%) |
| Dec 2024 | -$192.59M(-55.9%) | -$29.36M(+115.3%) | -$192.59M(-20.5%) |
| Sep 2024 | - | -$13.64M(-71.6%) | -$242.15M(-27.3%) |
| Jun 2024 | - | -$48.07M(-52.6%) | -$333.00M(-19.8%) |
| Mar 2024 | - | -$101.51M(+28.6%) | -$415.40M(-4.9%) |
| Dec 2023 | -$436.85M(-13.0%) | -$78.93M(-24.5%) | -$436.85M(-8.9%) |
| Sep 2023 | - | -$104.48M(-19.9%) | -$479.32M(-5.0%) |
| Jun 2023 | - | -$130.47M(+6.1%) | -$504.73M(+2.5%) |
| Mar 2023 | - | -$122.96M(+1.3%) | -$492.51M(-1.9%) |
| Dec 2022 | -$502.28M(+68.2%) | -$121.41M(-6.5%) | -$502.28M(+27.2%) |
| Sep 2022 | - | -$129.89M(+9.8%) | -$394.99M(+9.5%) |
| Jun 2022 | - | -$118.26M(-10.9%) | -$360.69M(+18.0%) |
| Mar 2022 | - | -$132.73M(+840.4%) | -$305.60M(+2.3%) |
| Dec 2021 | -$298.65M(-177.2%) | -$14.11M(-85.2%) | -$298.65M(-3.5%) |
| Sep 2021 | - | -$95.60M(+51.3%) | -$309.34M(-175.7%) |
| Jun 2021 | - | -$63.16M(-49.8%) | $408.58M(+10.3%) |
| Mar 2021 | - | -$125.78M(+407.2%) | $370.58M(-4.3%) |
| Dec 2020 | $387.04M(-239.2%) | -$24.80M(-104.0%) | $387.04M(+5.5%) |
| Sep 2020 | - | $622.33M(-715.2%) | $366.94M(-212.2%) |
| Jun 2020 | - | -$101.16M(-7.5%) | -$327.09M(+6.5%) |
| Mar 2020 | - | -$109.33M(+143.5%) | -$307.15M(+10.5%) |
| Dec 2019 | -$278.01M | -$44.90M(-37.4%) | -$278.01M(-7.5%) |
| Sep 2019 | - | -$71.70M(-11.7%) | -$300.70M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$81.23M(+1.3%) | -$284.00M(+38.1%) |
| Mar 2019 | - | -$80.19M(+18.7%) | -$205.63M(+17.5%) |
| Dec 2018 | -$175.01M(+46.0%) | -$67.58M(+22.9%) | -$175.01M(+23.1%) |
| Sep 2018 | - | -$55.01M(+1823.9%) | -$142.18M(+25.1%) |
| Jun 2018 | - | -$2.86M(-94.2%) | -$113.69M(-17.8%) |
| Mar 2018 | - | -$49.56M(+42.6%) | -$138.35M(+15.4%) |
| Dec 2017 | -$119.86M(+389.0%) | -$34.75M(+31.0%) | -$119.86M(+15.4%) |
| Sep 2017 | - | -$26.52M(-3.6%) | -$103.91M(+8.2%) |
| Jun 2017 | - | -$27.52M(-11.5%) | -$96.03M(+11.2%) |
| Mar 2017 | - | -$31.08M(+65.3%) | -$86.34M(+252.2%) |
| Dec 2016 | -$24.51M(-22.6%) | -$18.80M(+0.9%) | -$24.51M(+30.7%) |
| Sep 2016 | - | -$18.63M(+4.5%) | -$18.76M(+49.0%) |
| Jun 2016 | - | -$17.83M(-158.0%) | -$12.59M(+116.6%) |
| Mar 2016 | - | $30.75M(-335.7%) | -$5.82M(-81.6%) |
| Dec 2015 | -$31.68M(-10.5%) | -$13.05M(+4.7%) | -$31.68M(+4.9%) |
| Sep 2015 | - | -$12.46M(+12.8%) | -$30.21M(+14.8%) |
| Jun 2015 | - | -$11.05M(-326.1%) | -$26.31M(+10.1%) |
| Mar 2015 | - | $4.89M(-142.2%) | -$23.90M(-32.5%) |
| Dec 2014 | -$35.40M(+86.1%) | -$11.58M(+35.2%) | -$35.40M(+48.6%) |
| Sep 2014 | - | -$8.57M(-0.9%) | -$23.82M(+56.2%) |
| Jun 2014 | - | -$8.64M(+30.8%) | -$15.25M(+130.8%) |
| Mar 2014 | - | -$6.61M | -$6.61M |
| Dec 2013 | -$19.02M | - | - |
FAQ
- What is Blueprint Medicines annual cash flow from operations?
- What is the all time high annual CFO for Blueprint Medicines?
- What is Blueprint Medicines annual CFO year-on-year change?
- What is Blueprint Medicines quarterly cash flow from operations?
- What is the all time high quarterly CFO for Blueprint Medicines?
- What is Blueprint Medicines quarterly CFO year-on-year change?
- What is Blueprint Medicines TTM cash flow from operations?
- What is the all time high TTM CFO for Blueprint Medicines?
- What is Blueprint Medicines TTM CFO year-on-year change?
What is Blueprint Medicines annual cash flow from operations?
The current annual CFO of BPMC is -$192.59M
What is the all time high annual CFO for Blueprint Medicines?
Blueprint Medicines all-time high annual cash flow from operations is $387.04M
What is Blueprint Medicines annual CFO year-on-year change?
Over the past year, BPMC annual cash flow from operations has changed by +$244.26M (+55.91%)
What is Blueprint Medicines quarterly cash flow from operations?
The current quarterly CFO of BPMC is -$54.48M
What is the all time high quarterly CFO for Blueprint Medicines?
Blueprint Medicines all-time high quarterly cash flow from operations is $622.33M
What is Blueprint Medicines quarterly CFO year-on-year change?
Over the past year, BPMC quarterly cash flow from operations has changed by +$47.03M (+46.33%)
What is Blueprint Medicines TTM cash flow from operations?
The current TTM CFO of BPMC is -$145.55M
What is the all time high TTM CFO for Blueprint Medicines?
Blueprint Medicines all-time high TTM cash flow from operations is $408.58M
What is Blueprint Medicines TTM CFO year-on-year change?
Over the past year, BPMC TTM cash flow from operations has changed by +$269.85M (+64.96%)